Congenital Adrenal Hyperplasia Drug Market by Application The congenital adrenal hyperplasia (CAH) drug market is segmented based on various therapeutic applications, addressing both the treatment and management of this genetic disorder. One significant application is the hormone replacement therapy, primarily focused on providing synthetic glucocorticoids and mineralocorticoids to compensate for […]
Recent News